EGI
MYOK

EAM Global Investors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

EAM Global Investors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-23,255
Closed -$1.14M – 199
2018
Q1 		$1.14M Hold
23,255
– – 0.59% 84
2017
Q4 		$979K Buy
+23,255
New +$896K 0.5% 93

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Hillhouse Investment Management
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

EAM Global Investors's MYOK Position: Q2 2018 in Review

EAM Global Investors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2018, closing a stake of 23,255 shares — an estimated $1.14M sold.

EAM Global Investors first reported a position in MYOK in Q4 2017 and held it in 2 quarters. The position peaked at $1.14M in Q1 2018. 121 funds tracked by Wall St. Rank hold MYOK as of Q2 2018.

  • EAM Global Investors reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • EAM Global Investors sold 23,255 MyoKardia, Inc. Common Stock shares in Q2 2018, an estimated $1.14M.
  • EAM Global Investors first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • EAM Global Investors's MyoKardia, Inc. Common Stock position peaked at $1.14M in Q1 2018.
  • 121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2018.

Based on EAM Global Investors's 13F filing for Q2 2018, filed 3 Aug 2018.